SK Biopharmaceuticals Co., Ltd.
KRX:326030.KS
Overview | Financials
Company Name | SK Biopharmaceuticals Co., Ltd. |
Symbol | 326030.KS |
Currency | KRW |
Price | 104,300 |
Market Cap | 8,168,077,190,000 |
Dividend Yield | 0% |
52-week-range | 72,600 - 119,500 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Dong Hoon Lee |
Website | https://www.skbp.com |
An error occurred while fetching data.
About SK Biopharmaceuticals Co., Ltd.
SK Biopharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research, discovery, and development of drugs for the treatment of central nervous system disorders. The company is developing Cenobamate for the treatment of epilepsy; Solriamfetol for the treatment of excessive daytime sleepiness in narcolepsy or obstructive sleep apneal; Carisbamate that
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD